110 related articles for article (PubMed ID: 733993)
1. [Experience with the depot neuroleptic LyogenR-depot].
Bach O; Petermann H; Geppert V
Psychiatr Neurol Med Psychol (Leipz); 1978 Sep; 30(9):563-6. PubMed ID: 733993
[TBL] [Abstract][Full Text] [Related]
2. [Prolonged treatment of schizophrenic psychoses with depot-fluphenazine ("lyogen decanoate")].
Bohacek N; Mihovilović M
Neuropsihijatrija; 1968; 16(3):69-73. PubMed ID: 5195835
[No Abstract] [Full Text] [Related]
3. [Results of therapy with Lyogen-Depot in schizophrenic diseases].
Friemert K; Beier R; Vehreschild T
Psychiatr Neurol Med Psychol (Leipz); 1974 Jun; 26(6):374-7. PubMed ID: 4849639
[No Abstract] [Full Text] [Related]
4. Plasma levels of neuroleptic in patients receiving depot fluphenazine.
Cohen BM; Waternaux C; Chouinard G; Sommer BR; Jones B
J Clin Psychopharmacol; 1985 Dec; 5(6):328-32. PubMed ID: 4066997
[TBL] [Abstract][Full Text] [Related]
5. [Effect of moditen-depot therapy on the duration and quality of remissions in schizophrenia patients].
Vovin RIa; Gurovich IIa; Eryshev OF; Zaĭtsev SG; Magalif AIu
Zh Nevropatol Psikhiatr Im S S Korsakova; 1977; 77(5):743-9. PubMed ID: 899478
[TBL] [Abstract][Full Text] [Related]
6. [Depot fluphenazine as a means of stabilizing remission in cases of schizophrenia].
Vovin RIa; Vovina EN
Psychiatr Neurol Med Psychol Beih; 1975; 20-21():183-7. PubMed ID: 829620
[TBL] [Abstract][Full Text] [Related]
7. [Characteristics of the psychotropic activity of long-acting drugs (experience in the use of Moditen-depot)].
Smulevich AB; Minsker EI; Mazaeva NA; Volkova RP; Lukanina SK
Zh Nevropatol Psikhiatr Im S S Korsakova; 1972; 72(6):912-20. PubMed ID: 5050051
[No Abstract] [Full Text] [Related]
8. [The position of the depot-neuroleptics in the therapy of chronic psychoses. Experience with fluphenazine-decanoate].
Auch W
Med Welt; 1970 Oct; 21(41):1785-8. PubMed ID: 5471981
[No Abstract] [Full Text] [Related]
9. Discontinuation of oral and depot fluphenazine in schizophrenic patients after one year of continuous medication: a controlled study.
Levine J; Schooler NR; Severe J; Escobar J; Gelenberg A; Mandel M; Sovner R; Steinbook R
Adv Biochem Psychopharmacol; 1980; 24():483-93. PubMed ID: 6996445
[No Abstract] [Full Text] [Related]
10. [Long-term moditen-depot treatment of schizophrenic patients at a psychoneurology dispensary].
Abramova LI; Gushanskiĭ EL
Zh Nevropatol Psikhiatr Im S S Korsakova; 1986; 86(3):419-24. PubMed ID: 3705854
[TBL] [Abstract][Full Text] [Related]
11. Our experience with Moditene-Depot in chronic schizophrenia.
Gamkrelidze ShA; Putkoradze-Gamkrelidze NA
Act Nerv Super (Praha); 1973 Aug; 15(3):169. PubMed ID: 4769133
[No Abstract] [Full Text] [Related]
12. [Neuroleptic depot treatment of chronic psychoses with fluphenazine-dekanoate].
Weiser G; Gattringer B; Bengesser G
Wien Med Wochenschr; 1973 Apr; 123(14):227-30. PubMed ID: 4695598
[No Abstract] [Full Text] [Related]
13. The use of fluphenazine decanoate (Modecate)depot therapy in outpatient schizophrenics-a retrospective study.
Tan CT; Ong TC; Chee KT
Singapore Med J; 1981 Aug; 22(4):214-8. PubMed ID: 7323829
[No Abstract] [Full Text] [Related]
14. [Characteristics of the therapeutic action fluphenzaine decanoate (moditen-depot) in schizophrenia].
Tsutsul'kovskaia MIa; Minsker EI; Panteleeva GP; Mazurskii MB; Pekunova LG
Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(5):753-8. PubMed ID: 4718619
[No Abstract] [Full Text] [Related]
15. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
[No Abstract] [Full Text] [Related]
16. Depot neuroleptics in the treatment of acute psychoses.
Guarneri M; Placidi GF; Cassano GB
Encephale; 1979; 5(2):189-93. PubMed ID: 477594
[TBL] [Abstract][Full Text] [Related]
17. Tardive dyskinesia in outpatients on depot phenothiazine.
Neehall J
West Indian Med J; 1989 Dec; 38(4):228-33. PubMed ID: 2576166
[TBL] [Abstract][Full Text] [Related]
18. [Long-term treatment of schizophrenic psychoses using retard-neuroleptic preparations].
Andreas W
Med Welt; 1972 Apr; 23(15):566-7. PubMed ID: 4624926
[No Abstract] [Full Text] [Related]
19. Dose response of prophylactic antipsychotics.
Davis JM; Kane JM; Marder SR; Brauzer B; Gierl B; Schooler N; Casey DE; Hassan M
J Clin Psychiatry; 1993 Mar; 54 Suppl():24-30. PubMed ID: 8097195
[TBL] [Abstract][Full Text] [Related]
20. [Significance and advantages of Orap in the ambulatory care of schizophrenic psychoses].
König L; Lange E
Psychiatr Neurol Med Psychol (Leipz); 1976 Feb; 28(2):106-13. PubMed ID: 940884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
